Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Tacrolimus dosing to establish therapeutic levels in recipients of organ transplants is a challenging task because of much interpatient and intrapatient variability in drug absorption, metabolism, and disposition. In view of the reported impact of gut microbial species on drug metabolism, we investigated the relationship between the gut microbiota and tacrolimus dosing requirements in this pilot study of adult kidney transplant recipients. Serial fecal specimens were collected during the first month of transplantation from 19 kidney transplant recipients who either required a 50% increase from initial tacrolimus dosing during the first month of transplantation (Dose Escalation Group, n=5) or did not require such an increase (Dose Stable Group, n=14). We characterized bacterial composition in the fecal specimens by deep sequencing of the PCR amplified 16S rRNA V4-V5 region and we investigated the hypothesis that gut microbial composition is associated with tacrolimus dosing requirements. Initial tacrolimus dosing was similar in the Dose Escalation Group and in the Stable Group (4.2 ± 1.1 mg/day vs. 3.8 ± 0.8 mg/day, respectively, P=0.61, two-way between-group ANOVA using contrasts) but became higher in the Dose Escalation Group than in the Dose Stable Group by the end of the first transplantation month (9.6 ± 2.4 mg/day vs. 3.3 ± 1.5 mg/day, respectively, P<0.001). Our systematic characterization of the gut microbial composition identified that fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was 11.8% in the Dose Escalation Group and 0.8% in the Dose Stable Group (P=0.002, Wilcoxon Rank Sum test, P<0.05 after Benjamini-Hochberg correction for multiple hypotheses). Fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was positively correlated with future tacrolimus dosing at 1 month (R=0.57, P=0.01) and had a coefficient ± standard error of 1.0 ± 0.6 (P=0.08) after multivariable linear regression. Our novel observations may help further explain inter-individual differences in tacrolimus dosing to achieve therapeutic levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study examining kidney transplant patients found a positive correlation between patients that required an increase in tacrolimus dosing and the abundance of the gut bacterium Faecalibacterium prausnitzii149 (Fig. 5).”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Diet can impact gut microbial composition and structure [43] and whether dietary habits contributed to the gut microbial profile observed in this study is not known since we did not systematically collect diet history from our study subjects.”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., & Glockner, F. O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm864 · Cited by 6,668
Microbial degradation of complex carbohydrates in the gut
Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., & Forano, E. (2012) · Gut Microbes · doi:10.4161/gmic.19897 · Cited by 2,331
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Cited by
Items 201–234 of 234
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651610
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651613
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651601
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651595
Degraeve, A. L., Haufroid, V., Loriot, A. E., Gatto, L., Andries, V., Vereecke, L., Elens, L., & Bindels, L. B. (2023) · Figshare · doi:10.6084/m9.figshare.23632669
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651607
Degraeve, A. L., Haufroid, V., Loriot, A. E., Gatto, L., Andries, V., Vereecke, L., Elens, L., & Bindels, L. B. (2023) · Figshare · doi:10.6084/m9.figshare.23632666
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651604
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651598
医薬品―微生物間相互作用の解明を目的とした医薬品一斉分析系の構築と実践
Tsuchiya, Y. (2023) · Institutional Repositories DataBase (IRDB)
La transplantation de microbiote fécal : état des connaissances et pratiques
Lassiaz, M. (2023) · HAL
Dinu, L.-D., Vamanu, E., & Avram, I. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_7
Lauriola, M. (2025) · Lirias (KU Leuven)
Kafoor, N. F. A., & Elbadawi, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.23.701358
Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm
Arafat, A. M. A., Soliman, S. M. A., Elfandy, H., Othman, M. O., Elsayed, W., Lotfy, M. M., & Ebrahim, N. A. A. (2026) · World Journal of Transplantation · doi:10.5500/wjt.v16.i2.117357
He, J. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662368
Smółka, L., Strugała, M., Kursa, K., Blady, K., & Stanek, A. (2026) · Nutrients · doi:10.3390/nu18132056
Yasseen, M., & Elnour, A. (2026) · Kordofan Journal of Medical & Health Sciences · doi:10.70946/kjmhs3-2-26-p-104
Microbiome-Targeted Modulation in Renal Transplantation
Hau, H. M., Jahn, N., Karitnig, R., Hasenhütl, S. M., Sucher, R., Stiegler, P., & Laudi, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145648
Mohamed, M. E., Shen, C., Staley, C. M., Rashidi, A., Jurdi, N. E., Holtan, S. G., & Jacobson, P. A. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04152-x
Guan, Y., Wang, L., Kong, L.-X., Sun, Y.-Y., Zhou, J., Wang, X. L., Ma, Y., Guo, L.-P., Song, T.-R., Zhu, L., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01099-0
Zhang, Y., Hu, L., Ding, X., Liu, L., Xue, L., & Miao, L. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107626
Pain syndromes in transplantation: the role of the gut microbiome
Lockwood, M. B., Gallon, L., Kortan, E., & Tussing-Humphreys, L. M. (2026) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001308
The gut microbiome and allograft outcomes: implications for heart transplantation
Ðuran, I., Tang, W. H. W., & Mamic, P. (2026) · Journal of Clinical Investigation · doi:10.1172/jci207999
Microbiome: Artifacts in forensic toxicology qualitative and quantitative analysis
Dinis‐Oliveira, R. J., Martins, I. M., Costa, J. G., Freitas, A. R., Remião, F., & Oliveira, N. G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40634-8.00018-0
Zhang, Y., Yan, R., Wang, K., Wang, H., Gui, H., Man, J., & Yang, L. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179336
Gupta, K. H., Israni, A. K., & Onyeaghala, G. C. (2026) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001314
Zhang, T., Wang, S., Xu, X., & Renjie, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1938639
García-Ramírez, C. C., Martín-del-Campo, F., Ortíz-González, J. E., González-Heredia, T., & Cueto-Manzano, A. M. (2026) · Nutrients · doi:10.3390/nu18213502
Zhou, J., Zhang, R., Guo, P., Li, P., Huang, X., Wei, Y., Yang, C., Zhou, J., Yang, T., Liu, Y., et al. (2022) · doi:10.3389/fmicb.2022.1032290.s006
Metadata
- Authors
- Lee, J. R., Muthukumar, T., Dadhania, D., Taur, Y., Jenq, R. R., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Lee, John R.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-27
- Volume
- 10
- Issue
- 3
- Pages
- e0122399
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4376942
- OpenAlex
- W2073075095
- Cited by
- 211
- References
- 43
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 23 · 2023: 27 · 2022: 18 · 2021: 27 · 2020: 17 · 2019: 16 · 2018: 14 · 2017: 10 · 2016: 13 · 2015: 5
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR000458, UL1TR000457, UL1TR002384)
- National Cancer Institute (P30CA008748)
- National Institute of Allergy and Infectious Diseases (R37AI051652)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK087824)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- gut microbiota, tacrolimus dosing, kidney transplantation, Faecalibacterium prausnitzii, dose escalation, fecal microbiota, interpatient variability, drug metabolism, immunosuppression, therapeutic drug monitoring
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, Dose-Response Relationship, Drug, Feces, Female, Graft Rejection, Humans, Male, Middle Aged, RNA, Ribosomal, 16S, Kidney Transplantation, Tacrolimus, Transplant Recipients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.